Part,  Chapter, Paragraph

1   II,     5.  3.  9| Issues.~ ~Key T, Appleby P, Barnes I, Reeves G, Endogenous
2   II,     5.  9.  3|     in different countries, Barnes et al, (Barnes et al, 1996)
3   II,     5.  9.  3|   countries, Barnes et al, (Barnes et al, 1996) provided an
4   II,     5.  9.  7|  Immunol. 2006; 97:419-28~ ~Barnes PJ, Jon B (1996): The costs